Abstract:A cross‐sectional external validation study on 919 Chinese adults without a prior diabetes diagnosis recruited from public/private primary care clinics in Hong Kong. Our findings supported the external validity of the new non‐laboratory‐based models and the derived risk‐scoring algorithm in finding pre‐DM/DM cases in a primary care population. Aims/Introduction Two Hong Kong Chinese non‐laboratory‐based prediabetes/diabetes mellitus (pre‐DM/DM) risk models were developed using logistic regression (LR) and machine learning, respectively. We aimed to evaluate the models' validity in case finding of pre‐DM/DM in a Chinese primary care (PC) population. We also evaluated the validity of a risk‐scoring algorithm derived from the LR model. Materials and Methods This was a cross‐sectional external validation study on Chinese adults, without a prior DM diagnosis, who were recruited from public/private PC clinics in Hong Kong. A total of 1,237 participants completed a questionnaire on the models' predictors. Of that, 919 underwent blood glucose testing. The primary outcome was the models' and the algorithm's sensitivity in finding pre‐DM/DM cases. The secondary outcomes were the models' and the algorithm's specificity, positive/negative predictive values, discrimination and calibration. Results The models' sensitivity were 0.70 (machine learning) and 0.72 (LR). Both showed good external discrimination (area under the receiver operating characteristic curve: machine learning 0.744, LR 0.739). The risks estimated by the models were lower than the observed incidence, indicating poor calibration. Both models were more effective among participants with lower pretest probabilities; that is, age 18–44 years. The algorithm's sensitivity was 0.77 at the cut‐off score of ≥16 out of 41. Conclusion This study showed the validity of the models and the algorithm for finding pre‐DM/DM cases in a Chinese PC population in Hong Kong. They can facilitate more cost‐effective identification of high‐risk individuals for blood testing to diagnose pre‐DM/DM in PC. Further studies should recalibrate the models for more precise risk estimation in PC populations.

External Validation of Non-Invasive Diabetes Score in a 15-Year Prospective Study

A Novel Risk Score for Type 2 Diabetes Containing Sleep Duration: A 7-Year Prospective Cohort Study among Chinese Participants.

A SuperLearner approach for predicting diabetic kidney disease upon the initial diagnosis of T2DM in hospital

Three‐component Non‐invasive Risk Score for Undiagnosed Diabetes in Chinese People: Development, Validation and Longitudinal Evaluation

External Validation of the Prognostic Prediction Model for 4-Year Risk of Metabolic Syndrome in Adults: A Retrospective Cohort Study

Nonlaboratory-based Risk Assessment Algorithm for Undiagnosed Type 2 Diabetes Developed on a Nation-Wide Diabetes Survey.

Development and validation of a non-invasive assessment tool for screening prevalent undiagnosed diabetes in middle-aged and elderly Chinese

External validation of the Hong Kong Chinese non‐laboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care

Analysis of a Screening System for Diabetic Cardiovascular Autonomic Neuropathy in China.

Development and validation of a prediction model estimating the 10-year risk for type 2 diabetes in China

Development and external validation of a machine learning model to predict diabetic nephropathy in T1DM patients in the real-world

External validation of the risk prediction model for early diabetic kidney disease in Taiwan population: a retrospective cohort study

Cardiovascular disease risk prediction models for type 2 diabetes:verification in Chinese patients

Development and validation of a risk prediction model for early diabetic peripheral neuropathy based on a systematic review and meta-analysis

New risk‐scoring system including non‐alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort

[Applications of the NDR and DIAL models for risk prediction on cardiovascular disease in patients with type 2 diabetes in Ningbo].

Nonlaboratory-Based Risk Assessment Model for Type 2 Diabetes Mellitus Screening in Chinese Rural Population: A Joint Bagging-Boosting Model.

Development and validation of a machine learning‐based model to predict isolated post‐challenge hyperglycemia in middle‐aged and elder adults: Analysis from a multicentric study

Application and Improvement of Chinese Diabetes Risk Score on Screening Type 2 Diabetes Mellitus in Wuhai City, Inner Mongolia

New Diagnostic Model for the Differentiation of Diabetic Nephropathy From Non-Diabetic Nephropathy in Chinese Patients

Using noninvasive anthropometric indices to develop and validate a predictive model for metabolic syndrome in Chinese adults: a nationwide study